Hypericin as a non-antioxidant inhibitor of NF-κB

Planta Medica

Volumn 65, Issue 4, 1999, Pages 297-300

  Bork, Peter M ^a   Bacher, Susanne ^b   Schmitz, M Lienhard ^b   Kaspers, Uwe ^c   Heinrich, Michael ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c DR WILLMAR SCHWABE GMBH AND CO KG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROGEN PEROXIDE; HYPERICIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LUCIFERASE; PLANT EXTRACT; PROTEIN KINASE C; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL VIABILITY; DRUG ACTIVITY; DRUG TARGETING; ENZYME ACTIVITY; HELA CELL; IMMUNE RESPONSE; NONHUMAN; PHYTOCHEMISTRY; REPORTER GENE;

ANIMALS; CELL LINE; HELA CELLS; HUMANS; MICE; NF-KAPPA B; PERYLENE; TETRADECANOYLPHORBOL ACETATE; TUMOR NECROSIS FACTOR-ALPHA;

HYPERICUM PERFORATUM;

EID: 0032968509     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-1999-13989     Document Type: Article

References (17)

1. 1 de Smet, P. A. G. M., Nolen, W. A. (1996) Brit. Med. J. 313, 241-242.
2. 2 Müller, W. E., Singer, A., Wonnemann, M., Hafner, U., Roller, M., Schäfer, C. (1998) Pharmacopsychiatry 31 (Supplement), 16-21.
3. 3 Chatterjee, S. S., Bhattacharay, S. K., Wonnemann, M., Singer, A., Müller, E.W. (1998) Life Sc. 63 (6), 499-510.
4. 4 Butterweck, V., Petereit, F., Winterhoff, H., Nahrstedt, A. (1998) Planta Med 64, 291-294.
5. 5 Nahrstedt, A., Butterweck, V. (1997) Pharmacopsychiatry 30 (Suppl.), 129-134.
6. 6 Agostinis, P., Vandenbogaerde, A., Donella-Deana, A., Pinna, L. A., Lee, K.-T., Goris, J., Merlevede, W., Vandenheede, J. R., Witte, P. de (1995) Biochemical. Pharmacol. 49, 1615-1622.
7. 7 O'Neill, L. A. J., Kaltschmidt, C. (1997) Trends Neurol. Sc. 20, 252-258.
8. 8 Bork, P. M., Schmitz. M. L., Kuhnt, M., Escher, C., Heinrich, M. (1997) FEBS Lett. 402, 85-90.
9. 9 Vanden Berghe, W., Plaisance, S., Boone, E., Schmitz, M. L., Fiers, W., Haegeman, G. (1998) J. Biol. Chem. 273, 3285-3290.
10. 10 Schmitz, M. L., Hehner, S. P., Bacher, S., Dröge, W., Heinrich, M. (1998) Dtsch Apoth. Ztg. 138 (50), 4881-4891.
11. 11 Singh, S., Agarwal, B. B. (1995) J. Biol. Chem. 270, 24995-25000.
12. 12 Vincenti, M. P., Burrell, T. A., Taffet, S. M. (1992) J. Cell. Physiol 150, 204-213.
13. 13 Steffan, N. M., Bren, G. D., Frantz, B., Tocci, M. J., O'Neil, E. A., Paya, C. V. (1995) J. Immunol. 155, 4685-4691.
14. 14 Falk, H., Meyer, J. (1993) Monatsh. Chem. 124, 339-341.
15. 15 Erdelmeier, C. A. J. (1998) Pharmacopsychiatry 31 (Suppl.), 2-6.
16. 16 Bosscher, K. de, Schmitz, M. L., vanden Berghe, W., Plaisance, S., Fiers, W., Haegeman, S. (1997) Proc. Natl. Acad. Sci. (USA) 94, 13504-13509.
17. 17 Ausubel, F. M., Brent, R., Kingston, R. E. Moore, D. D., Seidman, J. G., Smith, J. A. Struhl, K., eds. (1998). Current Protocols in Molecular Biology. J. Wiley & Sons, New York.